We propose that in patients with GS, lack of NCC changes the composition and/or the volume of the endolymph compartment and that the renin–angiotensin system, activated by the renal loss of sodium, stimulates other salt transporters expressed by cells of the endolymphatic sac to partly counterbalance the defect. The gene discussed is SLC12A3; the disease is Gerstmann syndrome.